BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32278085)

  • 1. Combination of multiple tumor-infiltrating immune cells predicts clinical outcome in colon cancer.
    Zhang X; Quan F; Xu J; Xiao Y; Li X; Li Y
    Clin Immunol; 2020 Jun; 215():108412. PubMed ID: 32278085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
    Li X; Wen D; Li X; Yao C; Chong W; Chen H
    Front Immunol; 2020; 11():1678. PubMed ID: 33013820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.
    Zhou R; Zhang J; Zeng D; Sun H; Rong X; Shi M; Bin J; Liao Y; Liao W
    Cancer Immunol Immunother; 2019 Mar; 68(3):433-442. PubMed ID: 30564892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer.
    Kießler M; Plesca I; Sommer U; Wehner R; Wilczkowski F; Müller L; Tunger A; Lai X; Rentsch A; Peuker K; Zeissig S; Seifert AM; Seifert L; Weitz J; Bachmann M; Bornhäuser M; Aust D; Baretton G; Schmitz M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.
    Bense RD; Sotiriou C; Piccart-Gebhart MJ; Haanen JBAG; van Vugt MATM; de Vries EGE; Schröder CP; Fehrmann RSN
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27737921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
    Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
    Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.
    Che Y; Luo Z; Zhang C; Sun N; Gao S; He J
    Int Immunopharmacol; 2020 Oct; 87():106802. PubMed ID: 32745903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of tumor-infiltrating CD45RO⁺ memory T cells on human gastric cancer.
    Wakatsuki K; Sho M; Yamato I; Takayama T; Matsumoto S; Tanaka T; Migita K; Ito M; Hotta K; Nakajima Y
    Oncol Rep; 2013 May; 29(5):1756-62. PubMed ID: 23440298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic landscape of tumor-infiltrating immune cells in cervical cancer.
    Wang J; Li Z; Gao A; Wen Q; Sun Y
    Biomed Pharmacother; 2019 Dec; 120():109444. PubMed ID: 31562978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
    Xue Y; Li J; Lu X
    Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and characterization of tumor-infiltrating immune cells in breast cancer.
    Dai Q; Wu W; Amei A; Yan X; Lu L; Wang Z
    Int Immunopharmacol; 2021 Jan; 90():107167. PubMed ID: 33223469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
    Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
    Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
    Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
    Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune cell infiltration-associated signature in colon cancer and its prognostic implications.
    Deng D; Luo X; Zhang S; Xu Z
    Aging (Albany NY); 2021 Aug; 13(15):19696-19709. PubMed ID: 34349038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer.
    Liu J; Yi J; Zhang Z; Cao D; Li L; Yao Y
    Aging (Albany NY); 2021 Jun; 13(12):16513-16526. PubMed ID: 34157681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.